AU Stock MarketDetailed Quotes

Clarity Pharmaceuticals Ltd (CU6)

Watchlist
  • 3.320
  • -0.050-1.48%
20min DelayMarket Closed Jan 16 16:00 AET
1.24BMarket Cap-16.52P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Clarity Pharmaceuticals Ltd (CU6) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2025
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
Total revenue
Cost of revenue
Gross profit
Operating expense
39.51%78.56M
55.70%56.31M
19.39%36.16M
30.29M
Selling and administrative expenses
12.79%6.18M
170.43%5.48M
-77.67%2.03M
--9.07M
-General and administrative expense
12.79%6.18M
170.43%5.48M
-77.67%2.03M
--9.07M
Research and development costs
46.08%66.88M
45.53%45.78M
66.45%31.46M
--18.9M
Depreciation amortization depletion
20.92%185.08K
52.29%153.07K
117.33%100.51K
--46.25K
-Depreciation and amortization
20.92%185.08K
52.29%153.07K
117.33%100.51K
--46.25K
Other operating expenses
8.59%5.32M
89.74%4.89M
13.32%2.58M
--2.28M
Operating profit
-39.51%-78.56M
-55.70%-56.31M
-19.39%-36.16M
-30.29M
Net non-operating interest income (expenses)
71.84%4.76M
48.66%2.77M
1,860.46%1.86M
95.09K
Non-operating interest income
71.84%4.76M
48.66%2.77M
1,860.46%1.86M
--95.09K
Other net income (expenses)
-13.83%9.92M
17.41%11.51M
51.74%9.8M
6.46M
Other non-operating income (expenses)
-13.83%9.92M
17.41%11.51M
51.74%9.8M
--6.46M
Income before tax
-51.99%-63.88M
-71.55%-42.03M
-3.21%-24.5M
-23.74M
Income tax
41.12%416.51K
186.00%295.15K
485.30%103.2K
17.63K
Earnings from equity interest net of tax
Net income
-51.91%-64.3M
-72.03%-42.32M
-3.57%-24.6M
-23.75M
Net income continuous operations
-51.91%-64.3M
-72.03%-42.32M
-3.57%-24.6M
---23.75M
Noncontrolling interests
Net income attributable to the company
-51.91%-64.3M
-72.03%-42.32M
-3.57%-24.6M
-23.75M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-51.91%-64.3M
-72.03%-42.32M
-3.57%-24.6M
-23.75M
Diluted earnings per share
-29.68%-0.201
-63.66%-0.155
1.04%-0.0947
-0.0957
Basic earnings per share
-29.68%-0.201
-63.66%-0.155
1.04%-0.0947
-0.0957
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2025(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022
Total revenue
Cost of revenue
Gross profit
Operating expense 39.51%78.56M55.70%56.31M19.39%36.16M30.29M
Selling and administrative expenses 12.79%6.18M170.43%5.48M-77.67%2.03M--9.07M
-General and administrative expense 12.79%6.18M170.43%5.48M-77.67%2.03M--9.07M
Research and development costs 46.08%66.88M45.53%45.78M66.45%31.46M--18.9M
Depreciation amortization depletion 20.92%185.08K52.29%153.07K117.33%100.51K--46.25K
-Depreciation and amortization 20.92%185.08K52.29%153.07K117.33%100.51K--46.25K
Other operating expenses 8.59%5.32M89.74%4.89M13.32%2.58M--2.28M
Operating profit -39.51%-78.56M-55.70%-56.31M-19.39%-36.16M-30.29M
Net non-operating interest income (expenses) 71.84%4.76M48.66%2.77M1,860.46%1.86M95.09K
Non-operating interest income 71.84%4.76M48.66%2.77M1,860.46%1.86M--95.09K
Other net income (expenses) -13.83%9.92M17.41%11.51M51.74%9.8M6.46M
Other non-operating income (expenses) -13.83%9.92M17.41%11.51M51.74%9.8M--6.46M
Income before tax -51.99%-63.88M-71.55%-42.03M-3.21%-24.5M-23.74M
Income tax 41.12%416.51K186.00%295.15K485.30%103.2K17.63K
Earnings from equity interest net of tax
Net income -51.91%-64.3M-72.03%-42.32M-3.57%-24.6M-23.75M
Net income continuous operations -51.91%-64.3M-72.03%-42.32M-3.57%-24.6M---23.75M
Noncontrolling interests
Net income attributable to the company -51.91%-64.3M-72.03%-42.32M-3.57%-24.6M-23.75M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -51.91%-64.3M-72.03%-42.32M-3.57%-24.6M-23.75M
Diluted earnings per share -29.68%-0.201-63.66%-0.1551.04%-0.0947-0.0957
Basic earnings per share -29.68%-0.201-63.66%-0.1551.04%-0.0947-0.0957
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -